A carregar...
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
Colorectal cancer is one of the most common cancers worldwide. The prognosis of patients with metastatic colorectal cancer in recent years has increased from 5 months with best supportive care to nearly 2 years with chemotherapy combined with bevacizumab, an antivascular endothelial growth factor mo...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3460673/ https://ncbi.nlm.nih.gov/pubmed/23055745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S30581 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|